Targeting Cancer Resistance via Multifunctional Gold Nanoparticles

Resistance to chemotherapy is a major problem facing current cancer therapy, which is continuously aiming at the development of new compounds that are capable of tackling tumors that developed resistance toward common chemotherapeutic agents, such as doxorubicin (DOX). Alongside the development of n...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedrosa, Pedro, Corvo, M. Luísa, Ferreira-Silva, Margarida, Martins, Pedro, Carvalheiro, Manuela Colla, Costa, Pedro M., Martins, Carla, Martins, L. M. D. R. S., Baptista, Pedro V., Fernandes, Alexandra R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861975/
https://www.ncbi.nlm.nih.gov/pubmed/31694227
http://dx.doi.org/10.3390/ijms20215510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861975/
https://www.ncbi.nlm.nih.gov/pubmed/31694227
http://dx.doi.org/10.3390/ijms20215510

Ejemplares similares